Trivarx Ltd has released a press release.
Underwritten Share Purchase Plan Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from TrivarX
- MEB to Raise up to $3.5m By Way of a Placement and SPP
- Medibio Granted CE Mark Approval for MEBsleep
- Consumer Mental Health App Initial testing phase commenced
- US FDA advises further data needed for MEBsleep approval
- Update on Breakthrough Device Program
Later from TrivarX
- MEB Begins Implementation of ilumen In the United Kingdom
- Supplementary Prospectus
- MEB Share Purchase Plan Closes Strongly Oversubscribed
- Consumer Mental Health App Development - Second Test Phase
- Re-submission of FDA 510(k) application
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX